Researchers
Mihaljević, Biljana
Type
- 184 Conference Paper
- 130 Article
- 12 Monograph
- 2 Book parts
- 2 Other
- 1 Doctoral theses
- 1 Reviews
- 1 Text book
Date issued
- 30 2020 - 2027
- 242 2010 - 2019
- 59 2000 - 2009
- 2 1990 - 1999
Results 141-160 of 333
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2014 | The Role of immunophenotyping in differential diagnosis of chronic lymphocytic leukemia![]() | Dragović-Ivančević, Tijana; Kraguljac-Kurtović, Nada | Article | 23M23 |
| 2014 | Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study | Davies, Andrew; Merli, Francesco; Mihaljević, Biljana
MacDonald, David;
| Article | 21a+M21a+ |
| 2014 | Pretreatment risk factors for overall survival in patients with gastrointestinal and non-gastrointestinal mucosa associated lymphoid tissue lymphomas![]() | Virijević, Marijana | Article | 23M23 |
| 2014 | Therapeutic Outcome of Relapsed/Refractory Hodgkin Lymphoma Patients Treated with High Dose Therapy and Autologous Stem Cell Transplant: a Single Center Experience![]() | Todorović, Milena R. | Conference Paper | Mp. category will be shown later |
| 2013 | A Multicenter, Randomized Phase Iii Study of Rituximab as Maintenance Treatment Versus Observation Alone in Patients with Aggressive B-Cell Lymphoma: the Agmt Nhl13 Trial | Jaeger, Ulrich; ...; Mihaljevic, Biljana S | Conference Paper | Mp. category will be shown later |
| 2013 | A 10-Year Single-Center Experience in Primary Gastric Diffuse Large B Cell Lymphoma: from Presentation to Treatment and Prognosis | Antic, Darko A | Conference Paper | Mp. category will be shown later |
| 2013 | Extramedullary plasmacytoma of the tongue base - A rare presentation of head and neck plasmacytoma | Bila, Jelena | Article | 23M23 |
| 2013 | Analysis ofthe long term survival of patients with follicular lymphoma-our experience | Antić, Darko | Article | 53M53 |
| 2013 | CD5-positive versus CD5-negative diffuse large B-cell lymphoma treated with immunochemotherapy: Is there a difference? | Marisavljević, Dragomir Ž. | Conference Paper | Mp. category will be shown later |
| 2013 | Subcutaneous Rituximab and Chemotherapy Achieves Similar Trough Levels, Safety, and Response as Intravenous Rituximab in First-Line Follicular Lymphoma: Stage 1 Results of the Phase 3 Sabrina Study | Davies, Andrew; Merli, Francesco; Mihaljevic, Biljana S | Conference Paper | Mp. category will be shown later |
| 2013 | Differences in baseline characteristics and survival rates between GCB and non-GCB diffuse large B-cell lymphoma treated with rituximab based immunochemotherapy | Marisavljević, Dragomir Ž. | Conference Paper | Mp. category will be shown later |
| 2013 | Orbital and Ocular Adnexal Malt (Mucosa-Associated Lymphoid Tissue) Lymphomas, Ten Year Experience | Smiljanic, Mihailo; Milosevic, Rajko A; Antic, Darko A | Conference Paper | Mp. category will be shown later |
| 2013 | Immunoreactivity to food antigens in patients with plasmacytoma and multiple myeloma![]() | Kolundžija, Branka S. | Conference Paper | Mp. category will be shown later |
| 2013 | Prognostic Significance of Low Lymphocytes Count in the Patients with Diffuse Large B Cell Lymphoma (DLBCL) | Markovic, Olivera B; Popovic, Lazar S | Conference Paper | Mp. category will be shown later |
| 2013 | Stem cell-based (auto)grafting: from innovative research toward clinical use in regenerative medicine | Mihaljević, Biljana | Book parts | Mp. category will be shown later |
| 2013 | CD5-positive versus CD5-negative diffuse large B-cell lymphoma treated with immunochemotherapy: Is there a difference? (Meeting Abstract) | Popovic Ljubomir; Marković, Olivera | Conference Paper | Mp. category will be shown later |
| 2013 | c-FLIP does not correlate with response to immunochemotherapy treatment and outcome of patients with nodal diffuse large B-cell lymphoma | Marković, Olivera | Article | 22M22 |
| 2013 | Differences in baseline characteristics and survival rates between GCB and non-GCB diffuse large B-cell lymphoma treated with rituximab based immunochemotherapy (Meeting Abstract) | Popovic Ljubomir; Marković, Olivera | Conference Paper | Mp. category will be shown later |
| 2013 | Pharmacokinetics (PK), safety and overall response rate (ORR) achieved with subcutaneous (SC) administration of rituximab in combination with chemotherapy were comparable to those achieved with intravenous (IV) administration in patients (pts) with follic | Davies, AJ; Merli, Francesco; Mihaljevic, Biljana S | Conference Paper | Mp. category will be shown later |
| 2013 | Blast crisis of chronic myeloid leukemia: laboratory, immunophenotypc, and cytogenetic hallmarks and response to therapy | Vidović, A. | Conference Paper | Mp. category will be shown later |
